Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 83,891 | 103,702 | 161,249 | 125,704 | 60,839 |
| Operating Income | -83,891 | -103,702 | -161,249 | -125,704 | -60,839 |
| Other Income | 3,912 | 4,911 | 4,205 | -48 | 1,382 |
| Pre-tax Income | -79,979 | -98,792 | -157,044 | -125,752 | -59,456 |
| Net Income Continuous | -79,979 | -98,792 | -157,044 | -125,752 | -59,456 |
| Net Income | $-79,979 | $-98,792 | $-157,044 | $-125,752 | $-59,456 |
| EPS Basic Total Ops | -2.65 | -3.28 | -5.30 | -7.16 | -3.81 |
| EPS Basic Continuous Ops | -2.65 | -3.28 | -5.30 | -7.16 | -3.81 |
| EPS Diluted Total Ops | -2.65 | -3.28 | -5.30 | -7.16 | -3.81 |
| EPS Diluted Continuous Ops | -2.65 | -3.28 | -5.30 | -7.16 | -3.81 |
| EPS Diluted Before Non-Recurring Items | -2.65 | -3.28 | -5.30 | -7.16 | -3.81 |
| EBITDA(a) | $-83,891 | $-103,702 | $-161,249 | $-125,702 | $-60,835 |